Treatment strategies for patients with severe aplastic anemia

Bone Marrow Transplantation
Andrea Bacigalupo

Abstract

Treatment strategies for patients with severe aplastic anemia (SAA), depend on the severity of the disease, the age of the patient and the availability of a family donor. Progress in the past has included the early use of combined immunosuppressive therapy (IST) and better matching strategies to select unrelated donors. Currently, the actuarial 10-year survival in 2479 patients registered within the European Group for Blood and Marrow Transplantation (EBMT), is 73 and 68% for patients receiving first-line BMT or IST. The outcome of BMT has significantly improved since 1996, and this is true for both matched sibling donor BMT as well as for alternative donor BMT. Survival is significantly better in children (<16 years) as compared with adults (79 vs 68%, P<0.0001). In contrast, there has been no significant improvement over time for patients receiving IST. Again, results were significantly better in children compared with adults (81 versus 70%, P=0.001), especially in very severe aplasia (83 versus 62%, P=0.0002). This report outlines some of these results as a basis for treatment strategies in SAA.

References

Mar 27, 1976·Lancet·J AscensãoR Good
Jan 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J Y PiergaJ M Cosset
Jan 15, 1997·Annals of Internal Medicine·N S Young
May 15, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·H J DeegB Mueller
Dec 11, 2002·British Journal of Haematology·Eliane GluckmanUNKNOWN European Group for Blood and Marrow Transplantation Working Party for Severe Aplastic Anemia
Jun 21, 2005·Experimental Hematology·Andrea BacigalupoGiovanna Piaggio
Oct 6, 2005·Bone Marrow Transplantation·A BacigalupoUNKNOWN Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

❮ Previous
Next ❯

Citations

Apr 1, 1963·The American Journal of Medicine·E R MOVITTW R PORTER
Jul 6, 2012·The New England Journal of Medicine·Donald Metcalf
Jul 24, 2012·Advanced Drug Delivery Reviews·Miroslaw JanowskiPiotr Walczak
Aug 30, 2011·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Bela BalintMilica Cucuz-Jokic
Aug 26, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hazzaa Al-ZahraniMahmoud Aljurf
Dec 18, 2016·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Hanaa S E MousaAisha A El-Khodary
Sep 25, 2020·Journal of Pediatric Hematology/oncology·Fuxing LiXiaotian Xie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Philippe Armand, Joseph H Antin
Hematology/oncology Clinics of North America
Eva C Guinan
British Journal of Haematology
Judith MarshBritish Committee for Standards in Haematology
© 2022 Meta ULC. All rights reserved